Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPY4R | P50391 | 8/20 | 0.55 |
| ▸ | NPY1R | P25929 | 7/20 | 0.54 |
| ▸ | NPY2R | P49146 | 4/20 | 0.54 |
| ▸ | NPFFR1 | Q9GZQ6 | 2/20 | 0.46 |
| ▸ | NPFFR2 | Q9Y5X5 | 2/20 | 0.46 |
| ▸ | NPY5R | Q15761 | 2/20 | 0.46 |
| ▸ | CTSL | P07711 | 1/20 | 0.46 |
| ▸ | ERAP2 | Q6P179 | 2/20 | 0.46 |
| ▸ | ERAP1 | Q9NZ08 | 2/20 | 0.46 |
| ▸ | LNPEP | Q9UIQ6 | 2/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28275656 | 1.00 | NPY4R (0.55) | NPY4RNPY1RNPY2RNPFFR1NPFFR2 | |
| SCHEMBL28571247 | 0.85 | NPY4R (0.56) | NPY4RNPY1RNPY2RNPY5R | |
| SCHEMBL1449159 | 0.85 | NPY4R (0.56) | NPY4RNPY1RNPY2RNPY5R | |
| SCHEMBL29936161 | 0.83 | NPY4R (0.69) | NPY4RNPY1RNPY2RNPFFR1NPFFR2 | |
| SCHEMBL3055440 | 0.83 | CNR1 (0.49) | — | |
| SCHEMBL3046557 | 0.83 | CNR1 (0.49) | — | |
| SCHEMBL3055439 | 0.83 | CNR1 (0.49) | — | |
| SCHEMBL3046555 | 0.83 | CNR1 (0.49) | — | |
| SCHEMBL3055185 | 0.82 | CNR1 (0.50) | ERAP2ERAP1LNPEP | |
| SCHEMBL3055186 | 0.82 | CNR1 (0.50) | ERAP2ERAP1LNPEP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 101 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026089568-A1 | NOVEL PEPTIDE AND COMPOSITION FOR IMPROVING SKIN COMPRISING SAME | (주)아모레퍼시픽 | 2026-04-30 | — | — | WO | claimed |
| WO-2026046854-A1 | PEPTIDE CONTAINING HYDROGEL COMPOSITIONS | THE BOOTS COMPANY PLC (GB) | 2026-03-05 | — | — | WO | claimed |
| US-20250213463-A1 | TOPICAL COMPOSITION AND USES THEREOF | COTY INC. | 2025-07-03 | — | — | US | claimed |
| US-20250152494-A1 | COSMETIC COMPOSITION CONTAINING RETINOID, EXTRACT OF CENTELLA ASIATICA AND A DIPEPTIDE | THE BOOTS COMPANY PLC (GB) | 2025-05-15 | — | — | US | claimed |
| WO-2025096781-A1 | METHODS AND COMPOSITIONS FOR PROVIDING CUSTOMIZED SKIN REGIMENS | VIBRANT HOLDINGS, LLC (US) | 2025-05-08 | — | — | WO | claimed |
| WO-2025088285-A1 | ECOBIOLOGICAL TOPICAL COMPOSITION FOR TREATING SKIN REDNESS AND DISCOMFORT | NAOS INSTITUTE OF LIFE SCIENCE (FR) | 2025-05-01 | — | — | WO | claimed |
| EP-4493284-A1 | IMMEDIATE POST-PROCEDURE RECOVERY FORMULATION AND METHOD | Jamrm, LLC (US) | 2025-01-22 | — | — | EP | claimed |
| EP-4479021-A1 | COSMETIC COMPOSITION CONTAINING RETINOID, EXTRACT OF CENTELLA ASIATICA AND A DIPEPTIDE | The Boots Company PLC (GB) | 2024-12-25 | — | — | EP | claimed |
| CN-119072299-A | Cosmetic composition containing retinoid, centella asiatica extract and dipeptide | 布茨公司 | 2024-12-03 | — | — | CN | claimed |
| EP-4262997-A1 | EXTRACT OF BACTERIA OF THE GENUS SPHINGOMONAS | L'OREAL (FR) | 2023-10-25 | — | — | EP | claimed |
| WO-2023177739-A1 | IMMEDIATE POST-PROCEDURE RECOVERY FORMULATION AND METHOD | JAMRM, LLC (US) | 2023-09-21 | — | — | WO | claimed |
| WO-2023156072-A1 | COSMETIC COMPOSITION CONTAINING RETINOID, EXTRACT OF CENTELLA ASIATICA AND A DIPEPTIDE | THE BOOTS COMPANY PLC (GB) | 2023-08-24 | — | — | WO | claimed |
| WO-2022129549-A1 | EXTRACT OF BACTERIA OF THE GENUS SPHINGOMONAS | L'OREAL (FR) | 2022-06-23 | — | — | WO | claimed |
| WO-2026089568-A1 | NOVEL PEPTIDE AND COMPOSITION FOR IMPROVING SKIN COMPRISING SAME | (주)아모레퍼시픽 | 2026-04-30 | — | — | WO | disclosed |
| US-12594227-B2 | Tetrapeptide and compositions comprising tetrapeptides | THE BOOTS COMPANY PLC (GB) | 2026-04-07 | — | — | US | disclosed |
| EP-4704795-A2 | FRAGRANCE COMPOSITIONS | Coty Inc. (US) | 2026-03-11 | — | — | EP | disclosed |
| EP-4000597-A1 | TETRAPEPTIDE AND COMPOSITIONS COMPRISING TETRAPEPTIDES | The Boots Company plc (GB) | 2022-05-25 | — | — | EP | disclosed |
| EP-4000595-A1 | TETRAPEPTIDE AND COMPOSITIONS COMPRISING TETRAPEPTIDES | The Boots Company plc (GB) | 2022-05-25 | — | — | EP | disclosed |
| EP-4000598-A1 | TETRAPEPTIDE AND COMPOSITIONS COMPRISING TETRAPEPTIDES | The Boots Company plc (GB) | 2022-05-25 | — | — | EP | disclosed |
| EP-4000596-A1 | TETRAPEPTIDE AND COMPOSITIONS COMPRISING TETRAPEPTIDES | The Boots Company plc (GB) | 2022-05-25 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12594227-B2 | Tetrapeptide and compositions comprising tetrapeptides | SRRM2, SGTA, QARS1 | NPY4R 992/4885NPY1R 741/4885NPY2R 727/4885 |
| US-20250152494-A1 | COSMETIC COMPOSITION CONTAINING RETINOID, EXTRACT OF CENTELLA ASIATICA AND A DIPEPTIDE | RARA, RARG, RARB | NPY4R 839/4885NPY1R 1081/4885NPY2R 976/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.